SMYD3 and cancer: On the basis of these results, Lys 14 of AKT1 is likely to be a key amino acid to determine AKT1 activity through the electrostatic attraction with Glu 17 and the interaction with phosphoinositides; SMYD3-mediated methylation of Lys 14 may trigger the constitutive activation of AKT1 in cancer cells.